BNP Paribas Asset Management
IMNM icon

BNP Paribas Asset Management’s Immunome IMNM Stock Holding History

BNP Paribas Asset Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.5M Buy
1,250,275
+152,439
+14% +$3.26M 0.03% 514
2026
Q1 		$24M Buy
1,097,836
+915,457
+502% +$20.4M 0.03% 509
2025
Q4 		$3.92M Buy
182,379
+181,742
+28,531% +$3.19M ﹤0.01% 903
2025
Q3 		$7K Hold
637
– – ﹤0.01% 1736
2025
Q2 		$6K Buy
+637
New +$5.22K ﹤0.01% 1936

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

BNP Paribas Asset Management's IMNM Position: Q2 2026 in Review

BNP Paribas Asset Management increased its Immunome (IMNM) stake by 14% in Q2 2026, buying an estimated $3.26M and bringing the position to 1,250,275 shares worth $26.5M. The position accounts for 0.03% of the portfolio, ranked #514.

BNP Paribas Asset Management first reported a position in IMNM in Q2 2025 and has held it in 5 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • BNP Paribas Asset Management held 1,250,275 shares of Immunome worth $26.5M as of Q2 2026.
  • BNP Paribas Asset Management bought 152,439 Immunome shares in Q2 2026, an estimated $3.26M.
  • Immunome made up 0.03% of BNP Paribas Asset Management's portfolio in Q2 2026, its #514 holding.
  • BNP Paribas Asset Management first reported a position in Immunome in Q2 2025 and has held it in 5 quarters since.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.